Nivolumab combined with induction chemotherapy and radiotherapy in nasopharyngeal carcinoma: A multicenter phase 2 PLATINUM trialJun Ma, Guan-Qun Zhou, Wen-Fei Li et al.|Cancer Cell|2025Cited by 36
Toripalimab Combination Therapy Without Concurrent Cisplatin for Nasopharyngeal CarcinomaYusheng Jie, Cheng Xu, Xiaoyu Liang et al.|JAMA|2025Cited by 26
Efficacy and safety of second-line therapy with apatinib combined with chemotherapy as second-line therapy in advanced gastric cancer: a single-arm, open-label, prospective, multicenter studyYan Zhang, Bo Shen, Yang Yang et al.|Annals of Translational Medicine|2022Cited by 10
P3.18.39 PRESERVE-003: A Phase 3 Study of Gotistobart Versus Docetaxel in Metastatic NSCLC After Progression on PD-(L)1 InhibitorsTengfei Li, Mark A. Socinski, Yuan Wu et al.|Journal of Thoracic Oncology|2025Cited by 1